Weekly News

March 25 | 2026

The 2026 NASPGHAN Foundation grants application cycle will open April 1! These opportunities are made possible through the generous contributions of our donors.

See how your donations are making an impact to advance the field in research, clinical care and supporting the pipeline. ➡️➡️➡️➡️➡️➡️

Donate today!

Register for the NASPGHAN Foundation Grant Information session (tonight!), Wednesday, March 25 from 7:00pm-8pm ET to learn more about funding opportunities and ask questions.

https://us02web.zoom.us/meeting/register/wcW4-0GXRWSiH82UjsAY8A

The session recording will be available on www.naspghan.org.

See what funding opportunities in research, innovation, advocacy, and training you may be eligible for. Apply today!

https://tinyurl.com/2h9xd4z6

ON DEMAND WEBINARS

As therapeutic options for pediatric inflammatory bowel disease (IBD) rapidly evolve, clinicians must stay current on the next generation of therapies that have the potential to dramatically enhance patient outcomes and quality of life.

Emerging Therapeutic Frontiers in Pediatric IBD brings you an interactive, case-driven webinar that will delve into three groundbreaking areas transforming pediatric IBD care: IL-23 Blockade, JAK Inhibitors and Subcutaneous Biologic Medications. CME and MOC Part II credit available!

https://tinyurl.com/4jk6abxv

Obesity is a pervasive form of malnutrition that drives the development of MASLD, now the leading cause of chronic liver disease worldwide. Emerging evidence suggests that even moderate weight loss can yield significant improvements in liver steatosis, inflammation, and fibrosis. Proper nutrition may not only support weight loss, but also directly counteract steatosis and its progression. MASLD: What’s That Again? is an updated review of the AASLD guidance document on Pediatric MASLD. CME and MOC Part II credit available!

https://tinyurl.com/yc56zva3

FINAL CALL: Submit Your NASPGHAN SIG Proposal by March 31

Have an idea for a new NASPGHAN Special Interest Group (SIG)? Now is the time to act. NASPGHAN is accepting proposals for new SIGs for 2026—but the submission deadline is March 31st, and this will be the only opportunity to apply this year.

SIGs bring members together around emerging or specialized clinical, research, and educational topics not currently addressed through existing committees or initiatives. Proposals must demonstrate a clear connection to an existing NASPGHAN committee, with input and alignment from the parent committee chair strongly encouraged.

Click here to directly access the SIG Proposal application. For additional details, including the review process and list of current SIGs, visit the Call for SIG Proposals page

New Bill Exempts Health Care Professionals from H-1B Fee

Reps. Maria Elvira Salazar (R-FL), Mike Lawler (R-NY), Yvette Clarke (D-NY), and Sanford Bishop (D-GA), introduced this week legislation — the H-1Bs for Physicians and the Healthcare Workforce Act (H.R. 7961) — that would exempt health care professionals from the $100,000 H-1B petition fee which stems from a Proclamation issued by President Trump on Sept. 19, 2025.

The Proclamation provides no exception for physicians; although the Secretary of Homeland Security has the authority to grant exceptions to the fee in “extraordinarily rare” circumstances.

2026 Abstract Site NOW OPEN

We are pleased to announce that the Annual Meeting abstract submission site is now OPEN with a final submission deadline of June 1.

We encourage all members to begin preparing their submissions now and to share this information widely with trainees, colleagues, and collaborators.

What's New This Year?

NEW: Dedicated Quality Improvement Submission Pathway

Quality Improvement (QI) abstracts will have their own submission pathway this year, providing clearer review and categorization. As a reminder, 25 ABP MOC Part 4 credits remain available for authors of each qualifying QI abstract presentation.

NEW: Abstract Evaluation Rubrics are Available

Abstract evaluation rubrics will now be publicly posted for all abstract submitters to review. This is intended to provide transparency as well as clear guidance on evaluation criteria and help authors better align their submissions with review standards.

Poster Format Reminder

We will continue with the smaller poster format this year.

Posters should not exceed 4 feet × 4 feet in size.